Countries World
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...
July 17, 2024 | News
Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announce...
July 16, 2024 | News
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that it has completed its acquisiti...
July 11, 2024 | News
Clemens Plaschka, born 1989, receives the 20,000 euro award for his research on the molecular machines that generate and export messenger&nbs...
July 04, 2024 | News
Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful ...
July 02, 2024 | News
Renowned, experienced industry leader in newly created role for Cytiva Ruffieux joins Cytiva executive team on 1 July 2024 Cytiva is strength...
June 28, 2024 | News
Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The part...
June 13, 2024 | News
Royal Philips , a global leader in health technology, announced findings from its Sustainable Healthcare survey in Asia Pacific (APAC)...
June 06, 2024 | News
Fortrea, a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity an...
May 31, 2024 | News
Report highlights company’s commitments to all of its stakeholders and society Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in servin...
May 28, 2024 | Opinion
Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...
May 22, 2024 | News
OmniAb, reported financial results for the three months ended March 31, 2024, and provided operating and partner program updates. “The OmniAb t...
May 10, 2024 | Company results
Latus Bio, a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch a...
May 03, 2024 | News
Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatme...
May 03, 2024 | News
Most Read
Bio Jobs
News